BDKRB2 and Huntington disease: In addition, by providing the cell with a “survival” capacity, B2R antagonist is a legitimate therapeutic tool candidate, especially to treat diseases where apoptosis and excessive intracellular calcium release are the main players, such as Alzheimer’s disease [42] and Huntington’ disease [43].